Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Otago Medical School staff profiles

Dr Desiree Kunac

PositionResearch Fellow
DepartmentDepartment of Preventive and Social Medicine
QualificationsMPharm PhD
Research summaryNew Zealand Pharmacovigilance Centre

Research

  • Paediatric pharmacy
  • Paediatric drug safety
  • Adverse Drug Events
  • Medication error
  • Pharmacovigilance

Publications

Harrison-Woolrych, M., Tatley, M., & Kunac, D. (2014). Pharmacovigilance in New Zealand. In E. B. Andrews & N. Moore (Eds.), Mann's pharmacovigilance. (3rd ed.) (pp. 291-294). Chichester, UK: Wiley Blackwell. doi: 10.1002/9781118820186.ch16a

Kunac, D. L., Tatley, M. V., & Seddon, M. E. (2014). A new web-based Medication Error Reporting Programme (MERP) to supplement pharmacovigilance in New Zealand: Findings from a pilot study in primary care. New Zealand Medical Journal, 127(1401). Retrieved from http://www.nzma.org.nz/journal

Kunac, D., Tatley, M. V., Grimwood, K., & Reith, D. M. (2012). Active surveillance of serious adverse drug reactions in New Zealand children. Archives of Disease in Childhood, 97(8), 761-762. doi: 10.1136/archdischild-2011-301457

Kunac, D. L., & Tatley, M. V. (2011). Detecting medication errors in the New Zealand Pharmacovigilance Database: A retrospective analysis. Drug Safety, 34(1), 59-71. doi: 10.2165/11539290-000000000-00000

Kunac, D. L., Kennedy, J., Austin, N. C., & Reith, D. M. (2010). Risk factors for adverse drug events and medication errors in paediatric inpatients: Analysis by admission characteristics. Journal of Pharmacy Practice & Research, 40(4), 290-293.

Chapter in Book - Research

Harrison-Woolrych, M., Tatley, M., & Kunac, D. (2014). Pharmacovigilance in New Zealand. In E. B. Andrews & N. Moore (Eds.), Mann's pharmacovigilance. (3rd ed.) (pp. 291-294). Chichester, UK: Wiley Blackwell. doi: 10.1002/9781118820186.ch16a

^ Top of page

Journal - Research Article

Kunac, D. L., Tatley, M. V., & Seddon, M. E. (2014). A new web-based Medication Error Reporting Programme (MERP) to supplement pharmacovigilance in New Zealand: Findings from a pilot study in primary care. New Zealand Medical Journal, 127(1401). Retrieved from http://www.nzma.org.nz/journal

Kunac, D. L., & Tatley, M. V. (2011). Detecting medication errors in the New Zealand Pharmacovigilance Database: A retrospective analysis. Drug Safety, 34(1), 59-71. doi: 10.2165/11539290-000000000-00000

Kunac, D. L., Kennedy, J., Austin, N. C., & Reith, D. M. (2010). Risk factors for adverse drug events and medication errors in paediatric inpatients: Analysis by admission characteristics. Journal of Pharmacy Practice & Research, 40(4), 290-293.

Kunac, D. L., Kennedy, J., Austin, N., & Reith, D. (2009). Incidence, preventability, and impact of adverse drug events (ADEs) and potential ADEs in hospitalized children in New Zealand: A prospective observational cohort study. Pediatric Drugs, 11(2), 153-160. doi: 10.2165/00148581-200911020-00005

Savage, R. L., Kunac, D. L., & Johansson, J. (2009). Appraising the post-marketing safety of medicines: A description of national and international pharmacovigilance with a focus on medicines used in chronic pain. Current Anaesthesia & Critical Care, 20(5-6), 215-220. doi: 10.1016/j.cacc.2009.07.013

Tatley, M. V., Kunac, D. L., McNicholas, A., Zhou, L., Ballantyne, S., Ashton, J., … Reid, S. (2008). The Intensive Vaccines Monitoring Programme (IVMP): An electronic system to monitor vaccine safety in New Zealand. Vaccine, 26(22), 2746-2752. doi: 10.1016/j.vaccine.2008.03.017

Kunac, D. L., & Reith, D. M. (2008). Preventable medication-related events in hospitalised children in New Zealand. New Zealand Medical Journal, 121(1272), 17-32. Retrieved from http://journal.nzma.org.nz/journal/121-1272/3012/content.pdf

Kunac, D. L., Harrison-Woolrych, M., & Tatley, M. V. (2008). Pharmacovigilance in New Zealand: The role of the New Zealand Pharmacovigilance Centre in facilitating safer medicines use. New Zealand Medical Journal, 121(1283). Retrieved from http://journal.nzma.org.nz/journal/121-1283/3286/content.pdf

Kunac, D. L., Reith, D. M., Kennedy, J., Austin, N. C., & Williams, S. M. (2006). Inter- and intra-rater reliability for classification of medication related events in paediatric inpatients. Quality & Safety in Health Care, 15, 196-201.

Kunac, D. L., & Reith, D. M. (2005). Identification of priorities for medication safety in neonatal intensive care. Drug Safety, 28(3), 251-261.

Kunac, D., & Turner, S. (2001). Initial experience with a paediatric pharmacy e-mail network. Australian Journal of Hospital Pharmacy, 31, 139-142.

Kunac, D., Ball, P. A., & Broadbent, R. S. (1999). Study of the use of in-line intravenous filtration in neonates: Help or hindrance? Australian Journal of Hospital Pharmacy, 29(6), 321-327.

Kunac, D., Ball, P. A., & Woods, D. J. M. (1996). Paediatric therapeutics. 2 Assessing the sick child: to refer or not to refer? New Zealand Pharmacy, (March), 18-21.

^ Top of page

Journal - Research Other

Kunac, D., Tatley, M. V., Grimwood, K., & Reith, D. M. (2012). Active surveillance of serious adverse drug reactions in New Zealand children. Archives of Disease in Childhood, 97(8), 761-762. doi: 10.1136/archdischild-2011-301457

More publications...